228 related articles for article (PubMed ID: 15883478)
41. Myopathy associated with atorvastatin-ezetimibe combination therapy.
Weffald LA; Flach LA
Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
[TBL] [Abstract][Full Text] [Related]
42. Simvastatin-induced bilateral leg compartment syndrome and myonecrosis associated with hypothyroidism.
Ramdass MJ; Singh G; Andrews B
Postgrad Med J; 2007 Mar; 83(977):152-3. PubMed ID: 17344566
[TBL] [Abstract][Full Text] [Related]
43. Acute pancreatitis in a patient treated with micafungin.
Sato K; Hayashi M; Utsugi M; Ishizuka T; Takagi H; Mori M
Clin Ther; 2007 Jul; 29(7):1468-73. PubMed ID: 17825698
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
45. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
[TBL] [Abstract][Full Text] [Related]
46. Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
Tuteja S; Pyrsopoulos NT; Wolowich WR; Khanmoradi K; Levi DM; Selvaggi G; Weisbaum G; Tzakis AG; Schiff ER
Pharmacotherapy; 2008 Sep; 28(9):1188-93. PubMed ID: 18752389
[TBL] [Abstract][Full Text] [Related]
47. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
Broncel M; Balcerak M; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
[TBL] [Abstract][Full Text] [Related]
48. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
[TBL] [Abstract][Full Text] [Related]
49. Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis.
Tsesmeli NE; Giannoulis KE; Savopoulos CG; Vretou EE; Ekonomou IA; Giannoulis EK
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):805-6. PubMed ID: 17700268
[TBL] [Abstract][Full Text] [Related]
50. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
51. Aspirin-induced duodenal perforation in a Nigerian with sickle cell disease: a case report.
Salawu L; Olaomi OO; Paul-Odo B; Olayinka OS; Durosinmi MA
Niger Postgrad Med J; 2001 Jun; 8(2):90-2. PubMed ID: 11487909
[TBL] [Abstract][Full Text] [Related]
52. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
53. [Acute pancreatitis--induced by 5-aminosalicylic acid or an extraintestinal manifestation of ulcerative colitis?].
Petersen HH; Skovbjerg H
Ugeskr Laeger; 1995 Sep; 157(39):5400-1. PubMed ID: 7483055
[TBL] [Abstract][Full Text] [Related]
54. A prospective study of the aetiology, severity and outcome of acute pancreatitis in Eastern India.
Baig SJ; Rahed A; Sen S
Trop Gastroenterol; 2008; 29(1):20-2. PubMed ID: 18564662
[TBL] [Abstract][Full Text] [Related]
55. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
56. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
57. Pancreatitis following heart transplantation: report of a case.
Stefaniak T; Głowacki J; Dymecki D; Lachinski A; Gruca Z
Surg Today; 2003; 33(9):693-7. PubMed ID: 12928848
[TBL] [Abstract][Full Text] [Related]
58. Myopathy secondary to simvastatin in a type 2 diabetic patient.
Udawat H; Goyal RK
J Assoc Physicians India; 2002 Mar; 50():439-40. PubMed ID: 11922239
[TBL] [Abstract][Full Text] [Related]
59. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
Catapano A; Brady WE; King TR; Palmisano J
Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
[TBL] [Abstract][Full Text] [Related]
60. [Simvastatin-Induced Myopathy after Dose Increase].
Kandzia I; Kowar M; Frackowiak M; Jacobs AH
Dtsch Med Wochenschr; 2018 Dec; 143(24):1791-1794. PubMed ID: 30508862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
